The global Dysphagia Management Market is witnessing robust growth, with a substantial revenue of US$ 4.8 billion in 2024. Projections indicate that the market is poised to achieve a valuation of approximately US$ 7.8 billion by the end of 2031. Several factors are contributing to this impressive growth trajectory.
Rising Awareness Initiatives: Both governmental and private groups are taking proactive steps to raise awareness about dysphagia. With a rise in disposable income and growing demand for dysphagia management in healthcare services and medical facilities, the market is experiencing a surge in demand.
Growing Prevalence of Dysphagia: The increased prevalence of dysphagia, especially among the elderly population, is fueling the need for dysphagia management products and services. Innovative tools like fiberoptic endoscopic evaluation of swallowing (FEES) systems, neuromuscular electrical stimulation devices, and video fluoroscopy systems are expanding the market further.
Nasogastric and Percutaneous Endoscopic Gastrostomy Tubes: Nasogastric tubes and percutaneous endoscopic gastrostomy (PEG) tubes are in high demand as primary treatments for dysphagia. This demand has given local businesses the opportunity to offer affordable products, contributing to market growth.
Entry of Generic Medications: The rapid entry of generic medications in low-income countries, driven by cost-effective manufacturing and the availability of raw ingredients, is expanding the market's reach.
Documentation and Disease Evaluation: Lack of consistency in documenting dysphagia-related facts and incomplete evaluation of the disease can hinder market growth. The validity and reliability of various dysphagia assessments are often questioned by clinicians, impacting access to third-party payers and patient treatment compliance.
High Costs: The high cost of dysphagia control devices and the shortage of qualified healthcare workers capable of managing dysphagia pose challenges to market growth.
Japan: The Japanese dysphagia management market is highly competitive, with both domestic and international companies offering a wide range of products and services. Rising swallowing difficulties are expected to drive market expansion.
China: China's government initiatives in public health and the increasing use of advanced technology, including telemedicine and electronic medical records, are expected to boost demand for dysphagia management products and services, making it a prominent market.
This product will be delivered within 1-3 business days.
Driving Factors for Market Growth
Increasing Healthcare Expenditure: A significant factor driving the growth of the dysphagia management market is the increasing healthcare expenditure, which is enhancing infrastructure development in the healthcare sector.Rising Awareness Initiatives: Both governmental and private groups are taking proactive steps to raise awareness about dysphagia. With a rise in disposable income and growing demand for dysphagia management in healthcare services and medical facilities, the market is experiencing a surge in demand.
Growing Prevalence of Dysphagia: The increased prevalence of dysphagia, especially among the elderly population, is fueling the need for dysphagia management products and services. Innovative tools like fiberoptic endoscopic evaluation of swallowing (FEES) systems, neuromuscular electrical stimulation devices, and video fluoroscopy systems are expanding the market further.
Nasogastric and Percutaneous Endoscopic Gastrostomy Tubes: Nasogastric tubes and percutaneous endoscopic gastrostomy (PEG) tubes are in high demand as primary treatments for dysphagia. This demand has given local businesses the opportunity to offer affordable products, contributing to market growth.
Entry of Generic Medications: The rapid entry of generic medications in low-income countries, driven by cost-effective manufacturing and the availability of raw ingredients, is expanding the market's reach.
Potential Challenges for Market Growth
Side Effects and Discomfort: Dysphagia drugs and tubes may have undesirable side effects, potentially impeding market expansion. For instance, proton pump inhibitors, commonly used for dysphagia treatment, are associated with risks such as hip fractures and opportunistic infections.Documentation and Disease Evaluation: Lack of consistency in documenting dysphagia-related facts and incomplete evaluation of the disease can hinder market growth. The validity and reliability of various dysphagia assessments are often questioned by clinicians, impacting access to third-party payers and patient treatment compliance.
High Costs: The high cost of dysphagia control devices and the shortage of qualified healthcare workers capable of managing dysphagia pose challenges to market growth.
Country-Wise Insights
United States: The United States dominates the dysphagia management market due to its high prevalence of dysphagia and substantial healthcare spending. The region is witnessing increased attention to cutting-edge technologies, raising awareness and driving market growth.Japan: The Japanese dysphagia management market is highly competitive, with both domestic and international companies offering a wide range of products and services. Rising swallowing difficulties are expected to drive market expansion.
China: China's government initiatives in public health and the increasing use of advanced technology, including telemedicine and electronic medical records, are expected to boost demand for dysphagia management products and services, making it a prominent market.
Competitive Landscape
Manufacturers are playing a crucial role in creating awareness and are increasingly focused on acquisitions, mergers, product innovation, and development. Collaborations between universities and manufacturers are also contributing to advancements in dysphagia management.Key Companies Covered:
- Eisai Co. Ltd.
- Becton, Dickinson and Company (BD)
- AstraZeneca Plc.
- Cipla Limited
- Nestle (Nestle Health Science)
- Kent Corporation (Kent Precision Foods Group, Inc.)
- Danone (Nutricia Advanced Medical Nutrition)
- Cook Group (Cook Medical Inc.)
- Novartis AG
- Lannett
- Hormel Foods Corporation
- Abbott
- Ingredion Incorporated
- IFF Nutrition & Biosciences
- CP Kelco U.S., Inc.
- Deosen Biochemical (Ordos) Ltd.
- Brenntag Sdn. Bhd.
- R.T. Vanderbilt Holding Company, Inc.
- Flavour Creations
- Welltop Food Ingredients Sdn. Bhd
Key Segments Covered in Dysphagia Management Industry Research
Product:
- Drug (Proton Pump Inhibitors)
- Feeding Tubes
- Naso-Gastric Tubes
- PEG Tubes
- Nutritional Solutions
- Thickeners
- Beverages
- Purees
Indication:
- Oropharyngeal Dysphagia
- Esophageal Dysphagia
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Specialty Clinics
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Dysphagia Management Market Outlook, 2018 - 2031
4. North America Dysphagia Management Market Outlook, 2018 - 2031
5. Europe Dysphagia Management Market Outlook, 2018 - 2031
6. Asia Pacific Dysphagia Management Market Outlook, 2018 - 2031
7. Latin America Dysphagia Management Market Outlook, 2018 - 2031
8. Middle East & Africa Dysphagia Management Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Eisia Co.Ltd.
- Becton, Dickinson and Company (BD)
- AstraZeneca Plc.
- Cipla Limited
- Nestle (Nestle Health Science)
- Kent Corporation (Kent Precision Foods Groups, Inc.)
- Danone (Nutrica Advanced Medical Nutrition)
- Cook Group (Cook Medical Inc.)
- Novartis AG
- Lannett
- Hormel Foods Corporation
- Abbott
- Ingredion Incorporated
- IFF Nutrition & Biosciences
- CP Kelco U.S., Inc.
- Deosen Biochemical (Ordos) Ltd.
- Brenntag Sdn. Bhd.
- R.T. Vanderbilt Holding Company, Inc.
- Flavour Creations
- Welltop Food Ingredients Sdn. Bhd
Methodology
LOADING...
